636 related articles for article (PubMed ID: 24694989)
21. Is it possible to predict parameters of the Oxford classification of primary IgA Nephropathy from clinical laboratory data? Focus on the role of segmental glomerulosclerosis subtypes.
Monteiro MLGDR; Vieira MR; Pereira LHM; Araújo LS; Silva CA; Araújo LB; Rocha LP; Reis MAD; Machado JR
Pathol Res Pract; 2019 Oct; 215(10):152533. PubMed ID: 31320251
[TBL] [Abstract][Full Text] [Related]
22. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M
Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191
[TBL] [Abstract][Full Text] [Related]
23. Extracapillary proliferation is an independent predictive factor in Immunoglobulin A nephropathy.
Serriello I; Polci R; Feriozzi S; Gigante A; Di Giulio S; Rosa M; Galliani M; Morosetti M; Pugliese F; Petitti T; Onetti Muda A; Giannakakis K
Nephrology (Carlton); 2015 Sep; 20(9):654-9. PubMed ID: 25943286
[TBL] [Abstract][Full Text] [Related]
24. A validation study of crescents in predicting ESRD in patients with IgA nephropathy.
Zhang X; Shi S; Ouyang Y; Yang M; Shi M; Pan X; Lv J; Wang Z; Ren H; Shen P; Wang W; Zhang H; Xie J; Chen N
J Transl Med; 2018 May; 16(1):115. PubMed ID: 29724226
[TBL] [Abstract][Full Text] [Related]
25. The implications of focal segmental glomerulosclerosis in children with IgA nephropathy.
Trimarchi H; Coppo R
Pediatr Nephrol; 2020 Nov; 35(11):2043-2047. PubMed ID: 31773265
[TBL] [Abstract][Full Text] [Related]
26. Mesangial C4d deposition may predict progression of kidney disease in pediatric patients with IgA nephropathy.
Fabiano RCG; de Almeida Araújo S; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
Pediatr Nephrol; 2017 Jul; 32(7):1211-1220. PubMed ID: 28233100
[TBL] [Abstract][Full Text] [Related]
27. Immunoglobulin a nephropathy: Pathological markers of renal survival in paediatric patients.
Fabiano RC; Pinheiro SV; de Almeida Araújo S; Simões E Silva AC
Nephrology (Carlton); 2016 Dec; 21(12):995-1002. PubMed ID: 27414046
[TBL] [Abstract][Full Text] [Related]
28. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
Bellur SS; Troyanov S; Vorobyeva O; Coppo R; Roberts ISD;
Kidney Int; 2024 Jun; 105(6):1279-1290. PubMed ID: 38554992
[TBL] [Abstract][Full Text] [Related]
29. Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.
Yoon CY; Chang TI; Kang EW; Lim BJ; Kie JH; Kee YK; Kim H; Park S; Yun HR; Jung SY; Jhee JH; Kwon YE; Oh HJ; Park JT; Yoo TH; Kang SW; Jeong HJ; Han SH
Ann Med; 2017 May; 49(3):217-229. PubMed ID: 27764976
[TBL] [Abstract][Full Text] [Related]
30. Predictive value of sub classification of focal segmental glomerular sclerosis in Oxford classification of IgA nephropathy.
Yu F; Zhu X; Yuan S; Chen X; Li Z; Qu Z; Liu H; Sun L; Liu F
Ann Med; 2021 Dec; 53(1):587-595. PubMed ID: 33825605
[TBL] [Abstract][Full Text] [Related]
31. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
Bagchi S; Singh G; Yadav R; Kalaivani M; Mahajan S; Bhowmik D; Dinda A; Agarwal SK
Ren Fail; 2016; 38(3):431-6. PubMed ID: 26837482
[TBL] [Abstract][Full Text] [Related]
32. Evidence from the Oxford Classification cohort supports the clinical value of subclassification of focal segmental glomerulosclerosis in IgA nephropathy.
Bellur SS; Lepeytre F; Vorobyeva O; Troyanov S; Cook HT; Roberts IS;
Kidney Int; 2017 Jan; 91(1):235-243. PubMed ID: 27914703
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis.
Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H
Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066
[TBL] [Abstract][Full Text] [Related]
34. Prognostic role of glomerular electron microscopy lesions in IgA nephropathy: "the devil is in the details".
Terinte-Balcan G; Stancu S; Zugravu A; Capusa C; Radu A; Mircescu G; Stefan G
J Nephrol; 2023 Nov; 36(8):2233-2243. PubMed ID: 37632668
[TBL] [Abstract][Full Text] [Related]
35. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy.
Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB
J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969
[TBL] [Abstract][Full Text] [Related]
36. Validation of the Oxford classification of IgA nephropathy for pediatric patients from China.
Le W; Zeng CH; Liu Z; Liu D; Yang Q; Lin RX; Xia ZK; Fan ZM; Zhu G; Wu Y; Xu H; Zhai Y; Ding Y; Yang X; Liang S; Chen H; Xu F; Huang Q; Shen H; Wang J; Fogo AB; Liu ZH
BMC Nephrol; 2012 Nov; 13():158. PubMed ID: 23181565
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome in 145 patients with assumed benign immunoglobulin A nephropathy.
Knoop T; Vikse BE; Mwakimonga A; Leh S; Bjørneklett R
Nephrol Dial Transplant; 2017 Nov; 32(11):1841-1850. PubMed ID: 29106593
[TBL] [Abstract][Full Text] [Related]
38. IgA nephropathy: an update.
Soares MF; Roberts IS
Curr Opin Nephrol Hypertens; 2017 May; 26(3):165-171. PubMed ID: 28221174
[TBL] [Abstract][Full Text] [Related]
39. Pediatric IgA Nephropathy in Europe.
Coppo R
Kidney Dis (Basel); 2019 Jun; 5(3):182-188. PubMed ID: 31259180
[TBL] [Abstract][Full Text] [Related]
40. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation.
Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH
J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
